Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
TYPTF TRYPTAMINE THERAPEUTICS LIMITED
- 0.025
- +0.005+24.13%
15min DelayClose Dec 18 16:00 ET
31.85MMarket Cap-1.08P/E (TTM)
0.025High0.020Low29.35KVolume0.025Open0.020Pre Close730.37Turnover0.00%Turnover RatioLossP/E (Static)1.28BShares0.03952wk High8.32P/B31.85MFloat Cap0.00152wk Low--Dividend TTM1.28BShs Float0.039Historical High--Div YieldTTM24.63%Amplitude0.001Historical Low0.024Avg Price1Lot Size
TRYPTAMINE THERAPEUTICS LIMITED Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|
| Total revenue | 520.24%618.57K | 99.73K | |||
| Operating revenue | 520.24%618.57K | --99.73K | ---- | ---- | ---- |
| Cost of revenue | |||||
| Gross profit | 520.24%618.57K | 99.73K | |||
| Operating expense | -28.16%10.21M | 12.20%14.21M | 58.24%12.67M | 237.52%8M | 2.37M |
| Selling and administrative expenses | -32.85%6.5M | 17.61%9.68M | 71.73%8.23M | 251.40%4.79M | --1.36M |
| -Selling and marketing expense | -67.66%93.8K | -12.35%290.07K | 139.99%330.96K | --137.91K | ---- |
| -General and administrative expense | -31.77%6.41M | 18.87%9.39M | 69.71%7.9M | 241.29%4.65M | --1.36M |
| Research and development costs | -31.67%1.73M | -19.93%2.54M | 20.89%3.17M | 427.34%2.62M | --496.69K |
| Depreciation amortization depletion | -1.56%1.7M | 71.75%1.73M | 163.16%1.01M | 537.29%382.42K | --60.01K |
| -Depreciation and amortization | -1.56%1.7M | 71.75%1.73M | 163.16%1.01M | 537.29%382.42K | --60.01K |
| Other operating expenses | 2.71%276.74K | 1.81%269.45K | 25.35%264.65K | -53.21%211.14K | --451.28K |
| Operating profit | 32.04%-9.59M | -11.41%-14.11M | -58.24%-12.67M | -237.52%-8M | -2.37M |
| Net non-operating interest income expense | -300.58%-313.28K | -1,209.46%-78.21K | -88.36%7.05K | 110.43%60.58K | 28.79K |
| Non-operating interest income | 494.44%17.95K | -57.17%3.02K | -88.36%7.05K | 110.43%60.58K | --28.79K |
| Non-operating interest expense | 307.79%331.23K | --81.23K | ---- | ---- | ---- |
| Other net income (expense) | -32.44%2.77M | -2.03%4.11M | 57.26%4.19M | 2.67M | |
| Other non- operating income (expenses) | -32.44%2.77M | -2.03%4.11M | 57.26%4.19M | --2.67M | ---- |
| Income before tax | 29.29%-7.13M | -19.08%-10.08M | -60.42%-8.47M | -131.23%-5.28M | -2.28M |
| Income tax | 0 | 0 | 0 | 0 | 0 |
| Net income | 29.29%-7.13M | -19.08%-10.08M | -60.42%-8.47M | -131.23%-5.28M | -2.28M |
| Net income continuous Operations | 29.29%-7.13M | -19.08%-10.08M | -60.42%-8.47M | -131.23%-5.28M | ---2.28M |
| Minority interest income | |||||
| Net income attributable to the parent company | 29.29%-7.13M | -19.08%-10.08M | -60.42%-8.47M | -131.23%-5.28M | -2.28M |
| Preferred stock dividends | |||||
| Other preferred stock dividends | |||||
| Net income attributable to common stockholders | 29.29%-7.13M | -19.08%-10.08M | -60.42%-8.47M | -131.23%-5.28M | -2.28M |
| Basic earnings per share | 36.26%-0.0905 | 0.93%-0.142 | -15.30%-0.1433 | -39.45%-0.1243 | -0.0891 |
| Diluted earnings per share | 36.26%-0.0905 | 0.93%-0.142 | -15.30%-0.1433 | -39.45%-0.1243 | -0.0891 |
| Dividend per share | |||||
| Currency Unit | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
